You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

Pai Holdings Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for PAI HOLDINGS, and what generic and branded alternatives to PAI HOLDINGS drugs are available?

PAI HOLDINGS has forty-eight approved drugs.

Summary for Pai Holdings

US Patents:	0
Tradenames:	39
Ingredients:	33
NDAs:	48

Drugs and US Patents for Pai Holdings

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pai Holdings Pharm	PROPRANOLOL HYDROCHLORIDE	propranolol hydrochloride	SOLUTION;ORAL	071984-001	Mar 3, 1989		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Pai Holdings	MIDAZOLAM HYDROCHLORIDE	midazolam hydrochloride	INJECTABLE;INJECTION	078511-001	Nov 10, 2008		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Pai Holdings Pharm	ZINACEF	cefuroxime sodium	INJECTABLE;INJECTION	050558-004	Oct 23, 1986		DISCN	Yes	No		⤷ Sign Up				⤷ Sign Up
Pai Holdings Pharm	ZINACEF	cefuroxime sodium	INJECTABLE;INJECTION	050558-003	Oct 19, 1983		DISCN	Yes	No		⤷ Sign Up				⤷ Sign Up
Pai Holdings Pharm	LIDOCAINE HYDROCHLORIDE	lidocaine hydrochloride	SOLUTION;TOPICAL	204494-001	Mar 12, 2014	AT	RX	No	No		⤷ Sign Up				⤷ Sign Up
Pai Holdings Pharm	CIMETIDINE HYDROCHLORIDE	cimetidine hydrochloride	SOLUTION;ORAL	074664-001	Oct 28, 1997		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Pai Holdings Pharm	CLOBETASOL PROPIONATE	clobetasol propionate	GEL;TOPICAL	208881-001	Mar 6, 2017		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Pai Holdings

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pai Holdings Pharm	ZANTAC IN PLASTIC CONTAINER	ranitidine hydrochloride	INJECTABLE;INJECTION	019593-002	Sep 27, 1991	4,128,659	⤷ Sign Up
Pai Holdings Pharm	ZANTAC IN PLASTIC CONTAINER	ranitidine hydrochloride	INJECTABLE;INJECTION	019593-002	Sep 27, 1991	4,521,431*PED	⤷ Sign Up
Pai Holdings Pharm	ZANTAC	ranitidine hydrochloride	INJECTABLE;INJECTION	019090-001	Oct 19, 1984	4,128,658	⤷ Sign Up
Pai Holdings Pharm	ZANTAC IN PLASTIC CONTAINER	ranitidine hydrochloride	INJECTABLE;INJECTION	019593-002	Sep 27, 1991	4,585,790*PED	⤷ Sign Up
Pai Holdings Pharm	ZANTAC	ranitidine hydrochloride	INJECTABLE;INJECTION	019090-001	Oct 19, 1984	4,585,790*PED	⤷ Sign Up
Pai Holdings Pharm	ZANTAC IN PLASTIC CONTAINER	ranitidine hydrochloride	INJECTABLE;INJECTION	019593-002	Sep 27, 1991	4,128,658	⤷ Sign Up
Pai Holdings Pharm	ZANTAC IN PLASTIC CONTAINER	ranitidine hydrochloride	INJECTABLE;INJECTION	019593-001	Dec 17, 1986	4,585,790*PED	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.